Treatment of systolic heart failure
April 1997
New research findings will change the treatment of systolic heart failure.
ACE inhibitors are currently the cornerstone of therapy. They improve symptoms AND prolong survival.
Digoxin will be used less. The first long-term study shows that digoxin relieves the symptoms of heart failure...but it DOESN'T slow the progression of the disease or affect survival.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote